Why Pfizer's 'Mild' First-Quarter Report Likely Won't Satisfy SkepticsInvestors Business Daily • 05/05/26
Pfizer beats first-quarter profit estimates on strong demand for blood thinner EliquisReuters • 05/05/26
Pfizer vs Moderna: Only One Pharma Giant Is a Winner In The Post-Covid Era24/7 Wall Street • 05/04/26
Ahead of Pfizer (PFE) Q1 Earnings: Get Ready With Wall Street Estimates for Key MetricsZacks Investment Research • 04/30/26
Should You Forget This High-Yield Pharma Stock and Buy a Growth Name Instead?The Motley Fool • 04/30/26
Pfizer's ELREXFIO Significantly Improves Progression-Free Survival for Double-Class Exposed Patients with Relapsed or Refractory Multiple MyelomaBusiness Wire • 04/29/26